Northwestern Mutual Wealth Management
BBC icon

Northwestern Mutual Wealth Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-150
Closed -$4K – 2461
2019
Q2 		$4K Buy
+150
New +$4.19K ﹤0.01% 2148

Other funds holding BBC

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's BBC Position: Q3 2019 in Review

Northwestern Mutual Wealth Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2019, closing a stake of 150 shares — an estimated $4K sold.

Northwestern Mutual Wealth Management first reported a position in BBC in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 11 funds tracked by Wall St. Rank hold BBC as of Q3 2019.

  • Northwestern Mutual Wealth Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2019 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 150 Virtus Biotech Clinical Trials ETF shares in Q3 2019, an estimated $4K.
  • Northwestern Mutual Wealth Management first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2019 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Virtus Biotech Clinical Trials ETF position peaked at $4K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.